Chemical Name: 4-[[[3-Chloro-5-(trifluoromethyl)-2-pyridinyl][[4-(trifluoromethoxy)phenyl]methyl]amino]sulfonyl]benzoic acid
Biological ActivityPotent TRPM8 antagonist (IC50 values are 5.3 and 8.3 nM for rat and human channels respectively). Exhibits >350-fold selectivity for TRPM8 over TRPV4, TRPV1 and TRPA1. Reduces HSC3 and HSC4 oral squamous carcinoma cell migration and invasion in vitro. Also attenuates icilin-induced wet dog shakes in rats. Orally active.
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Blockade of TRPM8 activity reduces the invasion potential of oral squamous carcinoma cell lines.
Okamoto et al.
Identification of a novel 2-pyridyl-benzensulfonamide derivative, RQ-00203078, as a selective and orally active TRPM8 antagonist.
Ohmi et al.
Citation for RQ 00203078
The citations listed below are publications that use Tocris products. Selected citations for RQ 00203078 include:
1 Citation: Showing 1 - 1
Sustained MOR Administration Induces TRPM8-Dependent Cold Hyperalgesia.
Authors: Gong and Jasmin
J Pain 2017;18:212
No product specific FAQs exist for this product, however you mayView all Small Molecule FAQs
VersaClone cDNA Plasmids
Reviews for RQ 00203078
There are currently no reviews for this product. Be the first to review RQ 00203078 and earn rewards!
Have you used RQ 00203078?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image